Safety and Efficacy of Ultra Short-duration Dual Antiplatelet Therapy After Percutaneous Coronary Interventions: A Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Safety and Efficacy of Ultra Short-duration Dual Antiplatelet Therapy After Percutaneous Coronary Interventions: A Meta-analysis of Randomized Controlled Trials

Published:2022-10 Issue:10 Volume:47 Page:101295
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Abusnina Waiel^ORCID,Baral Nischit,Seri Amith,Ben-Dor Itsik,Alkhouli Mohamad,Monteleone Peter,Haddad Elias,Goldsweig Andrew M,Paul Timir K

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference35 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;Valgimigli;Eur Heart J,2018

2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease;Levine;J Am Coll Cardiol,2016

3. A conductive polymer hydrogel supports cell electrical signaling and improves cardiac function after implantation into myocardial infarct;Mihic;Circulation,2015

4. Recurrent stent thrombosis: an interventionalist's nightmare;Panaich;J Am Heart Assoc,2021

5. Risk factors and outcomes of recurrent drug-eluting stent thrombosis: insights from the REAL-ST registry;Enomoto;J Am Heart Assoc,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern ways to reduced mortality of myocardial infarction. What should be done?;Сибирский научный медицинский журнал;2023-10-27

2. Supporting patients to understand the variances in dual antiplatelet therapy treatment;British Journal of Cardiac Nursing;2023-10-02